Cellectis SA (CLLS)
4.01
+0.05
(+1.26%)
USD |
NASDAQ |
Feb 24, 13:17
Cellectis Price : 4.01 for Feb. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| EDAP TMS SA | 4.79 |
| DBV Technologies SA | 21.98 |
| Ascendis Pharma A/S | 233.03 |
| Akari Therapeutics Plc | 0.266 |
| Biodexa Pharmaceuticals Plc | 1.16 |
Price Related Metrics
| PS Ratio | 4.987 |
| Price to Book Value | 4.015 |
| Earnings Yield | -8.31% |
| Market Cap | 403.37M |